CRMD · Nasdaq · CIK 0001410098

CorMedix Inc.

CorMedix Inc.’s most recent SEC filing in our snapshot is a Form 8-K filed on Oct 19, 2026. In fiscal 2025 (year ended Dec 31, 2025) it reported revenue of $311.7M and net income of $163.1M, according to its XBRL data on EDGAR. Its EDGAR record lists 31 Form 4 insider filings from the 12 months before our last refresh.

SEC EDGAR snapshot updated Oct 27, 2026, 11:27 PM EDT. See all filings on sec.gov.

Revenue, FY2025
$311.7M
Net income, FY2025
$163.1M
Form 4 filings on record, past 12 months
31

Company overview

Legal name (as filed)
CorMedix Inc.
Ticker
CRMD
SEC Central Index Key (CIK)
0001410098
Industry (SIC)
Pharmaceutical Preparations (code 2834)
Business address
PARSIPPANY, NJ
State or country of incorporation
DE
Fiscal year ends
December 31
SEC filer category
Non-accelerated filer
Position in SEC ticker list
#2758 of the 3,000 companies we track

Five-year financial highlights

Full-year figures from CorMedix Inc.’s annual reports, as tagged in XBRL and published by the SEC. Amounts are in U.S. dollars; the fiscal year is named for the calendar year in which it ends.

Revenue
$190.9KFY2021$65.4KFY2022n/aFY2023$43.5MFY2024$311.7MFY2025
Net income
-$28.2MFY2021-$29.7MFY2022-$46.3MFY2023-$17.9MFY2024$163.1MFY2025
CRMD annual results
ItemFY2021
ended Dec 31, 2021		FY2022
ended Dec 31, 2022		FY2023
ended Dec 31, 2023		FY2024
ended Dec 31, 2024		FY2025
ended Dec 31, 2025
Revenue$190.9K$65.4K—$43.5M$311.7M
Net income-$28.2M-$29.7M-$46.3M-$17.9M$163.1M
Diluted EPS-$0.75-$0.74-$0.91-$0.30$2.04
Total assets$68.9M$62.0M$82.1M$118.8M$826.1M
Cash and equivalents$53.3M$43.1M$43.6M$40.7M$144.8M

XBRL tags used: revenue = Revenues; netIncome = NetIncomeLoss; assets = Assets; eps = EarningsPerShareDiluted; cash = CashAndCashEquivalentsAtCarryingValue. EPS is shown as originally reported for each year and may not be adjusted for later stock splits. A dash means the company did not report that item in a form we could match.

How to read these numbers

Revenue is the money a company brings in from selling its products and services; net income is what is left after all expenses, interest and taxes. Diluted EPS spreads net income across every share that could exist if options and convertible securities were exercised. Total assets and cash are balance-sheet figures measured on the last day of the fiscal year. For the full story — segment results, one-time charges, guidance — read Management’s Discussion and Analysis in the Form 10-K.

Latest key reports

The most recent filing of each major report type, even if it falls outside the 40 newest filings below.

CRMD latest annual, quarterly, current and proxy reports
FiledFormWhat it isOriginal
Mar 5, 202610-KANNUAL REPORT· period Dec 31, 2025Document · Index
Aug 13, 202610-QQuarterly report· period Jun 30, 2026Document · Index
Oct 19, 20268-KRegulation FD disclosure· period Oct 19, 2026Document · Index
Apr 29, 2026DEF 14APROXY STATEMENT· period Jun 23, 2026Document · Index

Recent SEC filings

The 40 newest documents filed by or about CorMedix Inc., by form type:

4 ×178-K ×11SCHEDULE 13G/A ×410-Q ×2S-8 POS ×1ARS ×1DEFA14A ×1DEF 14A ×1PRE 14A ×110-K ×1
CRMD recent filings
FiledFormWhat it isOriginal
Oct 19, 20268-KRegulation FD disclosure· period Oct 19, 2026Document · Index
Sep 18, 20264Statement of changes in beneficial ownership (insider trade)· period Sep 18, 2026Document · Index
Sep 1, 20264Statement of changes in beneficial ownership (insider trade)· period Aug 29, 2026Document · Index
Sep 1, 20264Statement of changes in beneficial ownership (insider trade)· period Aug 29, 2026Document · Index
Sep 1, 20264Statement of changes in beneficial ownership (insider trade)· period Aug 29, 2026Document · Index
Aug 13, 202610-QQuarterly report· period Jun 30, 2026Document · Index
Aug 13, 20268-KResults of operations· period Aug 13, 2026Document · Index
Aug 7, 20268-KOther events· period Aug 7, 2026Document · Index
Jul 2, 20268-KOther events· period Jun 29, 2026Document · Index
Jul 1, 20268-KAuditor change· period Jun 25, 2026Document · Index
Jun 25, 2026S-8 POSS-8 POSDocument · Index
Jun 24, 20268-KShareholder vote results· period Jun 23, 2026Document · Index
Jun 12, 2026SCHEDULE 13G/APassive beneficial ownership report (over 5%)Document · Index
Jun 12, 2026SCHEDULE 13G/APassive beneficial ownership report (over 5%)Document · Index
Jun 8, 20268-KRegulation FD disclosure· period Jun 8, 2026Document · Index
May 15, 2026SCHEDULE 13G/APassive beneficial ownership report (over 5%)Document · Index
May 14, 202610-QQuarterly report· period Mar 31, 2026Document · Index
May 14, 20268-KResults of operations· period May 14, 2026Document · Index
Apr 29, 2026ARSARS· period Dec 31, 2025Document · Index
Apr 29, 2026DEFA14ADEFINITIVE ADDITIONAL MATERIALSDocument · Index
Apr 29, 2026DEF 14APROXY STATEMENT· period Jun 23, 2026Document · Index
Apr 27, 20268-KRegulation FD disclosure· period Apr 27, 2026Document · Index
Apr 17, 2026PRE 14APROXY STATEMENT· period Apr 17, 2026Document · Index
Mar 26, 2026SCHEDULE 13G/APassive beneficial ownership report (over 5%)Document · Index
Mar 6, 20268-KRegulation FD disclosure· period Mar 6, 2026Document · Index
Mar 5, 202610-KANNUAL REPORT· period Dec 31, 2025Document · Index
Mar 5, 20268-KResults of operations· period Mar 5, 2026Document · Index
Feb 6, 20264Statement of changes in beneficial ownership (insider trade)· period Feb 4, 2026Document · Index
Feb 6, 20264Statement of changes in beneficial ownership (insider trade)· period Feb 4, 2026Document · Index
Feb 6, 20264Statement of changes in beneficial ownership (insider trade)· period Feb 4, 2026Document · Index
Jan 27, 20264Statement of changes in beneficial ownership (insider trade)· period Jan 23, 2026Document · Index
Jan 27, 20264Statement of changes in beneficial ownership (insider trade)· period Jan 23, 2026Document · Index
Jan 27, 20264Statement of changes in beneficial ownership (insider trade)· period Jan 23, 2026Document · Index
Jan 27, 20264Statement of changes in beneficial ownership (insider trade)· period Jan 23, 2026Document · Index
Jan 27, 20264Statement of changes in beneficial ownership (insider trade)· period Jan 26, 2026Document · Index
Jan 27, 20264Statement of changes in beneficial ownership (insider trade)· period Jan 26, 2026Document · Index
Jan 27, 20264Statement of changes in beneficial ownership (insider trade)· period Jan 26, 2026Document · Index
Jan 27, 20264Statement of changes in beneficial ownership (insider trade)· period Jan 26, 2026Document · Index
Jan 27, 20264Statement of changes in beneficial ownership (insider trade)· period Jan 26, 2026Document · Index
Jan 27, 20264Statement of changes in beneficial ownership (insider trade)· period Jan 26, 2026Document · Index

Insider filing activity

31 Form 4 filings appear in CorMedix Inc.’s EDGAR record between Oct 28, 2025 and our last refresh. Most are reports by the company’s own directors, officers and 10% owners, but EDGAR also lists a Form 4 under a company when the company itself is the insider — for example, when it owns more than 10% of another public company. Foreign private issuers’ own insiders generally do not file Form 4. A high count is not by itself a signal: many Form 4s report routine stock awards, tax withholding or sales under pre-arranged Rule 10b5-1 plans. Open each filing to see the transaction code, share count and price. What a Form 4 shows.

Other companies in Pharmaceutical Preparations

All 194 companies in Pharmaceutical Preparations· Companies headquartered in New Jersey

On Amazon

Popular tools for investors

As an Amazon Associate I earn from qualifying purchases.

Electronics Plaud Note Pro AI Voice Recorder An AI voice recorder that turns earnings calls and meetings into notes. View on Amazon → Electronics Amazon Kindle Paperwhite Signature Edition 32GB Read investing classics and long reports without eye strain. View on Amazon → Electronics Apple 2026 MacBook Air 13-inch Laptop A lightweight laptop for spreadsheets and filing research. View on Amazon →

Source

  • U.S. Securities and Exchange Commission, EDGAR submissions for CIK 0001410098 and XBRL company facts. CorMedix Inc. on EDGAR.
  • Snapshot updated Oct 27, 2026, 11:27 PM EDT. The SEC does not endorse OpenFilings. Company names and tickers are used only to identify the filer; no logos are shown.

Not investment advice. This page summarizes public SEC filings for information only. Figures may contain errors or omissions; confirm everything in the original filing before relying on it.